论文部分内容阅读
非肌层浸润性膀胱癌患者在经尿道膀胱肿瘤电切术(TURBT)后通常需进行膀胱灌注化疗,以减少术后肿瘤复发。本文通过互联网收集相关研究的随机临床对照试验(RCTs)并进行meta分析,以评价膀胱灌注中使用的不同化学药物的临床疗效。通过对Embase、Scopus和PubMed数据库进行检索收集随机对照试验数据,数据采集对象为TURBT术后即刻单药灌注的膀胱癌患者,包括单一病灶或多病灶,初诊或复发,
Non-muscle invasive bladder cancer in patients with bladder tumor after transurethral resection of the bladder (TURBT) usually need chemotherapy for bladder irrigation to reduce postoperative tumor recurrence. This article collects randomized controlled trials (RCTs) of related studies through the internet and conducts meta-analyzes to evaluate the clinical efficacy of different chemotherapeutics used in bladder perfusion. Randomized controlled trial data were collected by searching the Embase, Scopus and PubMed databases. The data were collected from patients with bladder cancer who had undergone immediate post-TURBT surgery, including single or multiple lesions, newly diagnosed or relapsed,